26 results
8-K
EX-2.1
CATX
Perspective Therapeutics Inc
12 Dec 23
Entry into a Material Definitive Agreement
8:05am
for the FDA to invoke its Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities Final Policy, (iv) been the subject of any investigation … by the FDA pursuant to its Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities Final Policy or (v) been, nor have any
8-K
EX-10.1
CATX
Perspective Therapeutics Inc
6 Dec 23
Entry into a Material Definitive Agreement
4:10pm
and regulations, including any anti-bribery and anti-corruption laws.
8.5. The Parties or any of their officials, employees, shareholders … -bribery or anti-corruption laws or regulations applicable to the Parties.
9. The present Contract shall come into effect upon signature and terminates
424B5
CATX
Perspective Therapeutics Inc
13 Jul 23
Prospectus supplement for primary offering
4:41pm
, as amended, or the FCPA, the U.S. domestic bribery statute contained in 18 U.S.C. § 201, the U.S. Travel Act, the USA PATRIOT Act, and possibly other state … and national anti-bribery and anti-money laundering laws in countries in which the Company conducts activities. Anti- corruption laws are interpreted
10-KT
vs525bzbvu0gxr5i1h4c
1 May 23
Annual report (with FYE transition)
5:03pm
8-K
EX-10.1
h0ia8 ehyq
14 Dec 22
Isoray Announces Adjournment of Annual Meeting
4:06pm
8-K
EX-10.2
mgceb4vgpeb k8h
14 Dec 22
Isoray Announces Adjournment of Annual Meeting
4:06pm
DEFM14A
fgv8 mqraogru
7 Nov 22
Proxy related to merger
5:20pm
PREM14A
gsfcj2rsnzykq6
25 Oct 22
Preliminary proxy related to merger
4:29pm
424B5
0155l1dbn g1mol2f
21 Oct 22
Prospectus supplement for primary offering
4:56pm
DEFA14A
EX-2.1
e7s1vjwuglm0k
28 Sep 22
Additional proxy soliciting materials
4:08pm
8-K
EX-2.1
yqa trc5yrb
28 Sep 22
Entry into a Material Definitive Agreement
4:07pm
424B5
fuw6x j3fgnpcuve40
1 Oct 21
Prospectus supplement for primary offering
4:23pm
8-K
EX-10.1
6y8x7pjdguu
23 Mar 21
Entry into a Material Definitive Agreement
4:24pm
424B5
lbl3x8ml 54kg67n0g
29 Sep 20
Prospectus supplement for primary offering
4:36pm